Dako Denmark A/S, Reagent Partnership Division, presented data and results of a validation study on The NGAL Test™ at the21st International Congress of Clinical Chemistry and Laboratory Medicine (IFCC-World Lab) in Berlin.
The poster which highlights the utility of NGAL as the ideal biomarker for diagnosing Acute Kidney Injury is entitled:"Quantitative determination of human plasma and urine Neutrophil Gelatinase Associated Lipocalin (NGAL) validation of an automated turbidimetric immunoassay" (P701).
Christensen PH. Holm SS. Kjøller C. Just T. and Heerfordt L., authors of the poster, presented it at the poster hall of the mentioned exhibition.
For viewing the poster, please click here or download the .pdf document on the right column of this page.